You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2010

FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices

Description of Resource: 
The Advisory Committee on Immunization Practices provides recommendations for the use of quadrivalent human papillomavirus vaccine in both males and females.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
CDC/MMWR
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Sexually Transmitted Diseases
Resource Type: 
Systematic Review
Citation: 
Centers for Disease Control and Prevention. FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR [Internet]. 2010 May 28 [cited 2015 Jul 24];59:626–629. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm